Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global Cancer-Induced Pain Clinical Trial Pipeline Highlights – 2021” report has been added to ResearchAndMarkets.com’s offering. Cancer-Induced Pain…
DUBLIN–(BUSINESS WIRE)–The “Global Glomerulonephritis Clinical Trial Pipeline Highlights – 2021” report has been added to ResearchAndMarkets.com’s offering. Glomerulonephritis Pipeline Highlights…
DUBLIN–(BUSINESS WIRE)–The “Global Glomerulonephritis Clinical Trial Pipeline Highlights – 2021” report has been added to ResearchAndMarkets.com’s offering. Glomerulonephritis Pipeline Highlights…
Approval based on the DESTINY-Breast01 phase 2 trial which showed clinically meaningful and durable responses in patients with previously treated…
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Gwenan White as Executive Vice President, Communications…
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Gwenan White as Executive Vice President, Communications…
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Gwenan White as Executive Vice President, Communications…
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Gwenan White as Executive Vice President, Communications…
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Gwenan White as Executive Vice President, Communications…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, announced…